Abstract
Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Current Psychopharmacology
Title:Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder
Volume: 5
Author(s): Deepak Moyal, Amit Khanna, Vishal Dhiman and Aninda Sidana
Affiliation:
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Abstract: Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Export Options
About this article
Cite this article as:
Moyal Deepak, Khanna Amit, Dhiman Vishal and Sidana Aninda, Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder, Current Psychopharmacology 2016; 5 (1) . https://dx.doi.org/10.2174/2211556005666160310001856
DOI https://dx.doi.org/10.2174/2211556005666160310001856 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Treatment of Chronic Hepatitis C not Responding to Interferon
Current Pharmaceutical Design Anesthetic Cardioprotection in Relation to Mitochondria: Basic Science
Current Pharmaceutical Design Exercise Induced Cardioprotection: An Overview of a Unique Form of Preconditioning
Current Cardiology Reviews Serum Adiponectin Levels in Patients with Familial Mediterranean Fever
Protein & Peptide Letters Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Current Medicinal Chemistry Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Current Clinical Pharmacology Patent Selections
Current Biomarkers (Discontinued) Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Arterial Stiffness As A Therapeutic Target For Isolated Systolic Hypertension: Focus on Vascular Calcification and Fibrosis
Current Hypertension Reviews Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
Current Drug Metabolism Antibody - Fc Receptor Interactions in Antimicrobial Functions
Current Immunology Reviews (Discontinued) Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design Homocysteine, Intracellular Signaling and Thrombotic Disorders
Current Medicinal Chemistry Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Triggering Receptor Expressed on Myeloid Cells (TREM) Family and the Application of Its Antagonists
Recent Patents on Anti-Infective Drug Discovery Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry